Selected research
Industry Research
Plant Sources Anti Cancer Agents Industry Research Report 2026
Market perspective
The global Plant Sources Anti Cancer Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Plant Sources Anti Cancer Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Plant Sources Anti Cancer Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Plant Sources Anti Cancer Agents include Yunnan Hande, Pfizer, Hainan Yew Pharm, West-Ward Pharmaceuticals, TAPI (Teva), Taj Pharma, Southpharma, ScinoPharm and Samyang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Plant Sources Anti Cancer Agents market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plant Sources Anti Cancer Agents Market by Company
Yunnan Hande
Pfizer
Hainan Yew Pharm
West-Ward Pharmaceuticals
TAPI (Teva)
Taj Pharma
Southpharma
ScinoPharm
Samyang
Salius
Polymed
Phyton
Novasep
Jiangsu Yew Biotechnology
Huiang biopharma
Getwell
Fresenius-kabi
Cipla
Actiza Pharmaceutical
Plant Sources Anti Cancer Agents Segment by Type
Paclitaxel
Vinorelbine
Irinotecan
Hydroxycamptothecin
Docetaxel
Other
Plant Sources Anti Cancer Agents Segment by Application
Breast Cancer
Ovarian Cancer
Cervical Cancer
Other
Plant Sources Anti Cancer Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Sources Anti Cancer Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant Sources Anti Cancer Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Sources Anti Cancer Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Plant Sources Anti Cancer Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Plant Sources Anti Cancer Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Plant Sources Anti Cancer Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Plant Sources Anti Cancer Agents Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Plant Sources Anti Cancer Agents Sales (tons) of Manufacturers (2021-2026)
Table 7. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Plant Sources Anti Cancer Agents Revenue of Manufacturers (2021-2026)
Table 9. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Plant Sources Anti Cancer Agents Average Price (US$/kg) of Manufacturers (2021-2026)
Table 11. Global Plant Sources Anti Cancer Agents Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application
Table 14. Global Plant Sources Anti Cancer Agents Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Plant Sources Anti Cancer Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Yunnan Hande Company Information
Table 19. Yunnan Hande Business Overview
Table 20. Yunnan Hande Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 21. Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
Table 22. Yunnan Hande Recent Developments
Table 23. Pfizer Company Information
Table 24. Pfizer Business Overview
Table 25. Pfizer Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 26. Pfizer Plant Sources Anti Cancer Agents Product Portfolio
Table 27. Pfizer Recent Developments
Table 28. Hainan Yew Pharm Company Information
Table 29. Hainan Yew Pharm Business Overview
Table 30. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 31. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
Table 32. Hainan Yew Pharm Recent Developments
Table 33. West-Ward Pharmaceuticals Company Information
Table 34. West-Ward Pharmaceuticals Business Overview
Table 35. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 36. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
Table 37. West-Ward Pharmaceuticals Recent Developments
Table 38. TAPI (Teva) Company Information
Table 39. TAPI (Teva) Business Overview
Table 40. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 41. TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
Table 42. TAPI (Teva) Recent Developments
Table 43. Taj Pharma Company Information
Table 44. Taj Pharma Business Overview
Table 45. Taj Pharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 46. Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
Table 47. Taj Pharma Recent Developments
Table 48. Southpharma Company Information
Table 49. Southpharma Business Overview
Table 50. Southpharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 51. Southpharma Plant Sources Anti Cancer Agents Product Portfolio
Table 52. Southpharma Recent Developments
Table 53. ScinoPharm Company Information
Table 54. ScinoPharm Business Overview
Table 55. ScinoPharm Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 56. ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
Table 57. ScinoPharm Recent Developments
Table 58. Samyang Company Information
Table 59. Samyang Business Overview
Table 60. Samyang Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 61. Samyang Plant Sources Anti Cancer Agents Product Portfolio
Table 62. Samyang Recent Developments
Table 63. Salius Company Information
Table 64. Salius Business Overview
Table 65. Salius Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 66. Salius Plant Sources Anti Cancer Agents Product Portfolio
Table 67. Salius Recent Developments
Table 68. Polymed Company Information
Table 69. Polymed Business Overview
Table 70. Polymed Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 71. Polymed Plant Sources Anti Cancer Agents Product Portfolio
Table 72. Polymed Recent Developments
Table 73. Phyton Company Information
Table 74. Phyton Business Overview
Table 75. Phyton Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 76. Phyton Plant Sources Anti Cancer Agents Product Portfolio
Table 77. Phyton Recent Developments
Table 78. Novasep Company Information
Table 79. Novasep Business Overview
Table 80. Novasep Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 81. Novasep Plant Sources Anti Cancer Agents Product Portfolio
Table 82. Novasep Recent Developments
Table 83. Jiangsu Yew Biotechnology Company Information
Table 84. Jiangsu Yew Biotechnology Business Overview
Table 85. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 86. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
Table 87. Jiangsu Yew Biotechnology Recent Developments
Table 88. Huiang biopharma Company Information
Table 89. Huiang biopharma Business Overview
Table 90. Huiang biopharma Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
Table 92. Huiang biopharma Recent Developments
Table 93. Getwell Company Information
Table 94. Getwell Business Overview
Table 95. Getwell Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. Getwell Plant Sources Anti Cancer Agents Product Portfolio
Table 97. Getwell Recent Developments
Table 98. Fresenius-kabi Company Information
Table 99. Fresenius-kabi Business Overview
Table 100. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
Table 102. Fresenius-kabi Recent Developments
Table 103. Cipla Company Information
Table 104. Cipla Business Overview
Table 105. Cipla Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Cipla Plant Sources Anti Cancer Agents Product Portfolio
Table 107. Cipla Recent Developments
Table 108. Actiza Pharmaceutical Company Information
Table 109. Actiza Pharmaceutical Business Overview
Table 110. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
Table 112. Actiza Pharmaceutical Recent Developments
Table 113. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 114. Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (tons)
Table 115. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2026)
Table 116. Global Plant Sources Anti Cancer Agents Sales by Region (2027-2032) & (tons)
Table 117. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2027-2032)
Table 118. Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026) & (US$ Million)
Table 119. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2026)
Table 120. Global Plant Sources Anti Cancer Agents Revenue by Region (2027-2032) & (US$ Million)
Table 121. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2027-2032)
Table 122. North America Plant Sources Anti Cancer Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. North America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 124. North America Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 125. North America Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (US$ Million)
Table 126. North America Plant Sources Anti Cancer Agents Revenue by Country (2027-2032) & (US$ Million)
Table 127. Europe Plant Sources Anti Cancer Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 129. Europe Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 130. Europe Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (US$ Million)
Table 131. Europe Plant Sources Anti Cancer Agents Revenue by Country (2027-2032) & (US$ Million)
Table 132. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 134. Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 135. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (US$ Million)
Table 136. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country (2027-2032) & (US$ Million)
Table 137. South America Plant Sources Anti Cancer Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. South America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 139. South America Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 140. South America Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (US$ Million)
Table 141. South America Plant Sources Anti Cancer Agents Revenue by Country (2027-2032) & (US$ Million)
Table 142. Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 144. Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 145. Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country (2021-2026) & (US$ Million)
Table 146. Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country (2027-2032) & (US$ Million)
Table 147. Global Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons)
Table 148. Global Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons)
Table 149. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2026)
Table 150. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2027-2032)
Table 151. Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (US$ Million)
Table 152. Global Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (US$ Million)
Table 153. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2026)
Table 154. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2027-2032)
Table 155. Global Plant Sources Anti Cancer Agents Price by Type (2021-2026) & (US$/kg)
Table 156. Global Plant Sources Anti Cancer Agents Price by Type (2027-2032) & (US$/kg)
Table 157. Global Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons)
Table 158. Global Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons)
Table 159. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2026)
Table 160. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2027-2032)
Table 161. Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (US$ Million)
Table 162. Global Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (US$ Million)
Table 163. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2026)
Table 164. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2027-2032)
Table 165. Global Plant Sources Anti Cancer Agents Price by Application (2021-2026) & (US$/kg)
Table 166. Global Plant Sources Anti Cancer Agents Price by Application (2027-2032) & (US$/kg)
Table 167. Key Raw Materials
Table 168. Raw Materials Key Suppliers
Table 169. Plant Sources Anti Cancer Agents Distributors List
Table 170. Plant Sources Anti Cancer Agents Customers List
Table 171. Plant Sources Anti Cancer Agents Industry Trends
Table 172. Plant Sources Anti Cancer Agents Industry Drivers
Table 173. Plant Sources Anti Cancer Agents Industry Restraints
Table 174. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Plant Sources Anti Cancer Agents Product Image
Figure 5. Global Plant Sources Anti Cancer Agents Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Plant Sources Anti Cancer Agents Market Size (2021-2032) & (US$ Million)
Figure 7. Global Plant Sources Anti Cancer Agents Sales (2021-2032) & (tons)
Figure 8. Global Plant Sources Anti Cancer Agents Average Price (US$/kg) & (2021-2032)
Figure 9. Paclitaxel Product Image
Figure 10. Vinorelbine Product Image
Figure 11. Irinotecan Product Image
Figure 12. Hydroxycamptothecin Product Image
Figure 13. Docetaxel Product Image
Figure 14. Other Product Image
Figure 15. Breast Cancer Product Image
Figure 16. Ovarian Cancer Product Image
Figure 17. Cervical Cancer Product Image
Figure 18. Other Product Image
Figure 19. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers in 2025
Figure 20. Global Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters
Figure 21. Global Top 5 and 10 Plant Sources Anti Cancer Agents Players Market Share by Revenue in 2025
Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 24. Global Plant Sources Anti Cancer Agents Sales by Region in 2025
Figure 25. Global Plant Sources Anti Cancer Agents Revenue by Region in 2025
Figure 26. North America Plant Sources Anti Cancer Agents Market Size by Country in 2025
Figure 27. North America Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 28. North America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2021-2032)
Figure 29. United States Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Canada Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Mexico Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Europe Plant Sources Anti Cancer Agents Market Size by Country in 2025
Figure 33. Europe Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 34. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Country (2021-2032)
Figure 35. Germany Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. France Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. U.K. Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Italy Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Russia Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Spain Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Netherlands Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Switzerland Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Sweden Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Poland Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Asia Pacific Plant Sources Anti Cancer Agents Market Size by Country in 2025
Figure 46. Asia Pacific Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 47. Asia Pacific Plant Sources Anti Cancer Agents Revenue Market Share by Country (2021-2032)
Figure 48. China Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Japan Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South Korea Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. India Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Australia Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Taiwan Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Southeast Asia Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Southeast Asia Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. South America Plant Sources Anti Cancer Agents Market Size by Country in 2025
Figure 57. South America Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 58. South America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2021-2032)
Figure 59. Brazil Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Argentina Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Chile Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Middle East and Africa Plant Sources Anti Cancer Agents Market Size by Country in 2025
Figure 63. Middle East and Africa Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 64. Middle East and Africa Plant Sources Anti Cancer Agents Revenue Market Share by Country (2021-2032)
Figure 65. Egypt Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. South Africa Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Israel Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. Türkiye Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 69. GCC Countries Plant Sources Anti Cancer Agents Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 70. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032)
Figure 71. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032)
Figure 72. Global Plant Sources Anti Cancer Agents Price (US$/kg) by Type (2021-2032)
Figure 73. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032)
Figure 74. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032)
Figure 75. Global Plant Sources Anti Cancer Agents Price (US$/kg) by Application (2021-2032)
Figure 76. Plant Sources Anti Cancer Agents Value Chain
Figure 77. Plant Sources Anti Cancer Agents Production Mode & Process
Figure 78. Direct Comparison with Distribution Share
Figure 79. Distributors Profiles
Figure 80. Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
Scope & coverage.
Types
- Paclitaxel
- Vinorelbine
- Irinotecan
- Hydroxycamptothecin
- Docetaxel
- Other
Applications
- Breast Cancer
- Ovarian Cancer
- Cervical Cancer
- Other
Companies covered
- Yunnan Hande
- Pfizer
- Hainan Yew Pharm
- West-Ward Pharmaceuticals
- TAPI (Teva)
- Taj Pharma
- Southpharma
- ScinoPharm
- Samyang
- Salius
- Polymed
- Phyton
- Novasep
- Jiangsu Yew Biotechnology
- Huiang biopharma
- Getwell
- Fresenius-kabi
- Cipla
- Actiza Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Plant Sources Anti Cancer Agents Market Size (2021-2032)
- 2.2.2 Global Plant Sources Anti Cancer Agents Sales (2021-2032)
- 2.2.3 Global Plant Sources Anti Cancer Agents Market Average Price (2021-2032)
- 2.3 Plant Sources Anti Cancer Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Paclitaxel
- 2.3.3 Vinorelbine
- 2.3.4 Irinotecan
- 2.3.5 Hydroxycamptothecin
- 2.3.6 Docetaxel
- 2.3.7 Other
- 2.4 Plant Sources Anti Cancer Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Ovarian Cancer
- 2.4.4 Cervical Cancer
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Plant Sources Anti Cancer Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Plant Sources Anti Cancer Agents Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Plant Sources Anti Cancer Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Plant Sources Anti Cancer Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Plant Sources Anti Cancer Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application
- 3.8 Global Manufacturers of Plant Sources Anti Cancer Agents, Established Date
- 3.9 Global Plant Sources Anti Cancer Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yunnan Hande
- 4.1.1 Yunnan Hande Company Information
- 4.1.2 Yunnan Hande Business Overview
- 4.1.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
- 4.1.5 Yunnan Hande Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Hainan Yew Pharm
- 4.3.1 Hainan Yew Pharm Company Information
- 4.3.2 Hainan Yew Pharm Business Overview
- 4.3.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
- 4.3.5 Hainan Yew Pharm Recent Developments
- 4.4 West-Ward Pharmaceuticals
- 4.4.1 West-Ward Pharmaceuticals Company Information
- 4.4.2 West-Ward Pharmaceuticals Business Overview
- 4.4.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
- 4.4.5 West-Ward Pharmaceuticals Recent Developments
- 4.5 TAPI (Teva)
- 4.5.1 TAPI (Teva) Company Information
- 4.5.2 TAPI (Teva) Business Overview
- 4.5.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
- 4.5.5 TAPI (Teva) Recent Developments
- 4.6 Taj Pharma
- 4.6.1 Taj Pharma Company Information
- 4.6.2 Taj Pharma Business Overview
- 4.6.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
- 4.6.5 Taj Pharma Recent Developments
- 4.7 Southpharma
- 4.7.1 Southpharma Company Information
- 4.7.2 Southpharma Business Overview
- 4.7.3 Southpharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio
- 4.7.5 Southpharma Recent Developments
- 4.8 ScinoPharm
- 4.8.1 ScinoPharm Company Information
- 4.8.2 ScinoPharm Business Overview
- 4.8.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
- 4.8.5 ScinoPharm Recent Developments
- 4.9 Samyang
- 4.9.1 Samyang Company Information
- 4.9.2 Samyang Business Overview
- 4.9.3 Samyang Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio
- 4.9.5 Samyang Recent Developments
- 4.10 Salius
- 4.10.1 Salius Company Information
- 4.10.2 Salius Business Overview
- 4.10.3 Salius Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Salius Plant Sources Anti Cancer Agents Product Portfolio
- 4.10.5 Salius Recent Developments
- 4.11 Polymed
- 4.11.1 Polymed Company Information
- 4.11.2 Polymed Business Overview
- 4.11.3 Polymed Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio
- 4.11.5 Polymed Recent Developments
- 4.12 Phyton
- 4.12.1 Phyton Company Information
- 4.12.2 Phyton Business Overview
- 4.12.3 Phyton Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio
- 4.12.5 Phyton Recent Developments
- 4.13 Novasep
- 4.13.1 Novasep Company Information
- 4.13.2 Novasep Business Overview
- 4.13.3 Novasep Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio
- 4.13.5 Novasep Recent Developments
- 4.14 Jiangsu Yew Biotechnology
- 4.14.1 Jiangsu Yew Biotechnology Company Information
- 4.14.2 Jiangsu Yew Biotechnology Business Overview
- 4.14.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
- 4.14.5 Jiangsu Yew Biotechnology Recent Developments
- 4.15 Huiang biopharma
- 4.15.1 Huiang biopharma Company Information
- 4.15.2 Huiang biopharma Business Overview
- 4.15.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
- 4.15.5 Huiang biopharma Recent Developments
- 4.16 Getwell
- 4.16.1 Getwell Company Information
- 4.16.2 Getwell Business Overview
- 4.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio
- 4.16.5 Getwell Recent Developments
- 4.17 Fresenius-kabi
- 4.17.1 Fresenius-kabi Company Information
- 4.17.2 Fresenius-kabi Business Overview
- 4.17.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
- 4.17.5 Fresenius-kabi Recent Developments
- 4.18 Cipla
- 4.18.1 Cipla Company Information
- 4.18.2 Cipla Business Overview
- 4.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio
- 4.18.5 Cipla Recent Developments
- 4.19 Actiza Pharmaceutical
- 4.19.1 Actiza Pharmaceutical Company Information
- 4.19.2 Actiza Pharmaceutical Business Overview
- 4.19.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
- 4.19.5 Actiza Pharmaceutical Recent Developments
5 Global Plant Sources Anti Cancer Agents Market Scenario by Region
- 5.1 Global Plant Sources Anti Cancer Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Plant Sources Anti Cancer Agents Sales by Region: 2021-2032
- 5.2.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2021-2026
- 5.2.2 Global Plant Sources Anti Cancer Agents Sales by Region: 2027-2032
- 5.3 Global Plant Sources Anti Cancer Agents Revenue by Region: 2021-2032
- 5.3.1 Global Plant Sources Anti Cancer Agents Revenue by Region: 2021-2026
- 5.3.2 Global Plant Sources Anti Cancer Agents Revenue by Region: 2027-2032
- 5.4 North America Plant Sources Anti Cancer Agents Market Facts & Figures by Country
- 5.4.1 North America Plant Sources Anti Cancer Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 5.4.3 North America Plant Sources Anti Cancer Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Plant Sources Anti Cancer Agents Market Facts & Figures by Country
- 5.5.1 Europe Plant Sources Anti Cancer Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 5.5.3 Europe Plant Sources Anti Cancer Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Plant Sources Anti Cancer Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Plant Sources Anti Cancer Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Plant Sources Anti Cancer Agents Market Facts & Figures by Country
- 5.7.1 South America Plant Sources Anti Cancer Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 5.7.3 South America Plant Sources Anti Cancer Agents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Plant Sources Anti Cancer Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Plant Sources Anti Cancer Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
- 6.1.1 Global Plant Sources Anti Cancer Agents Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
- 6.2.1 Global Plant Sources Anti Cancer Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Plant Sources Anti Cancer Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
- 7.1.1 Global Plant Sources Anti Cancer Agents Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
- 7.2.1 Global Plant Sources Anti Cancer Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Plant Sources Anti Cancer Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Plant Sources Anti Cancer Agents Value Chain Analysis
- 8.1.1 Plant Sources Anti Cancer Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Plant Sources Anti Cancer Agents Production Mode & Process
- 8.2 Plant Sources Anti Cancer Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Plant Sources Anti Cancer Agents Distributors
- 8.2.3 Plant Sources Anti Cancer Agents Customers
9 Global Plant Sources Anti Cancer Agents Analyzing Market Dynamics
- 9.1 Plant Sources Anti Cancer Agents Industry Trends
- 9.2 Plant Sources Anti Cancer Agents Industry Drivers
- 9.3 Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
- 9.4 Plant Sources Anti Cancer Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst